Director General of the Indian Council of Medical Research (ICMR) Dr Balaram Bhargava said that the indigenous Covid-19 vaccines would be effective against new variants of the corona virus that has been reported in Britain, South Africa and Brazil . Such indications have been indicated by the interim results of ongoing clinical trials of these vaccines.
Addressing an international webinar ‘Kerala Health: Making the SDGs a Reality’ organized by the Department of Health and Family Welfare, Government of Kerala here on Thursday, Bhargava said that the ability of covicin against the new type of Covid-19 that came to the fore in the UK A paper has been accepted for publication.
He said that in the case of types in South Africa and Brazil, efforts are being made to isolate the mutated virus from samples collected from travelers from these two countries. The official said that the third clinical trial of Covaxin BB-152 has been completed as both doses have been given to all 25,800 volunteers involved in this exercise. He said that the interim analysis report should arrive in a week.
Dr. Bhargava pointed out that India used this period to increase the capacity of both government and private medical infrastructure against the Covid-19 outbreak in response to keeping the spread of the epidemic under control.
He said that unlike many European countries, including Britain and Italy, India was against the idea of achieving collective deterrence. He said that judging by the situation in the western countries that allowed the epidemic to spread, the decision proved to be correct.